Denise O Leung, MD, MSc
Associate Professor of Neurology
[email protected]

Available to mentor

Denise O Leung, MD, MSc
Clinical Associate Professor
  • Qualifications
  • Center Memberships
  • Recent Publications
  • Qualifications
    • Neuro-Oncology Fellow
      Henry Ford Hospital, United States, 2014
    • Neurology Resident
      Henry Ford Hospital, Neurology, 2012
    • Transitional Year Resident
      Henry Ford Hospital, United States, 2009
    Center Memberships
    • Center Member
      Precision Health Initiative
    Recent Publications See All Publications
    • Proceeding / Abstract / Poster
      CTNI-61. MYCOPHENOLATE MOFETIL INHIBITS GLIOBLASTOMA PURINE METABOLISM IN HUMANS: AN INTERIM RESULT OF PHASE 0/1 CLINICAL TRIAL TO OVERCOME TREATMENT RESISTANCE IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
      Umemura Y, Al-Holou W, Elaimy A, Scott AJ, Leung D, Clarke N, Kim MM, Ferris S, Thomas J, Heth J, Schipper M, Suresh K, Lawrence T, Wahl D. Neuro-Oncology, 2023 Nov 10; 25 (Supplement_5): v90 - v90. DOI:10.1093/neuonc/noad179.0343
    • Journal Article
      Metabolomic Profiles of Human Glioma Inform Patient Survival.
      Scott AJ, Correa LO, Edwards DM, Sun Y, Ravikumar V, Andren AC, Zhang L, Srinivasan S, Jairath N, Verbal K, Muraszko K, Sagher O, Carty SA, Hervey-Jumper S, Orringer D, Kim MM, Junck L, Umemura Y, Leung D, Venneti S, Camelo-Piragua S, Lawrence TS, Ippolito JE, Al-Holou WN, Chinnaiyan P, Heth J, Rao A, Lyssiotis CA, Wahl DR. Antioxid Redox Signal, 2023 Nov; 39 (13-15): 942 - 956. DOI:10.1089/ars.2022.0085
      PMID: 36852494
    • Journal Article
      Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.
      Umemura Y, Orringer D, Junck L, Varela ML, West MEJ, Faisal SM, Comba A, Heth J, Sagher O, Leung D, Mammoser A, Hervey-Jumper S, Zamler D, Yadav VN, Dunn P, Al-Holou W, Hollon T, Kim MM, Wahl DR, Camelo-Piragua S, Lieberman AP, Venneti S, McKeever P, Lawrence T, Kurokawa R, Sagher K, Altshuler D, Zhao L, Muraszko K, Castro MG, Lowenstein PR. Lancet Oncol, 2023 Sep; 24 (9): 1042 - 1052. DOI:10.1016/S1470-2045(23)00347-9
      PMID: 37657463
    • Proceeding / Abstract / Poster
      Abstract 1093: Measuring and inhibiting purine metabolism in patients with glioblastoma
      Umemura Y, Scott AJ, Al-Holou W, Mittal A, Zhou W, Wilder-Romans K, Xu J, Qi N, Kachman M, Kim M, Junck L, Leung D, Clarke N, Heth J, Wen B, Pai A, Tarnal V, Nagrath D, Lawrence T, Lyssiotis CA, Wahl DR. Cancer Research, 2023 Apr 4; 83 (7_Supplement): 1093 - 1093. DOI:10.1158/1538-7445.am2023-1093
    • Journal Article
      IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases.
      Fleege NMG, Pierce-Gjeldum D, Swartz LK, Verbal K, Merajver S, Friese CR, Kiyota A, Heth J, Leung D, Smith SR, Gabel N, Kim MM, Morikawa A. JCO Oncol Pract, 2023 Jan; 19 (1): e67 - e77. DOI:10.1200/OP.22.00291
      PMID: 36223556
    • Proceeding / Abstract / Poster
      CTNI-35. PHASE 0/1 TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH CHEMORADIATION TO OVERCOME TREATMENT RESISTANCE IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA BY TARGETING PURINE METABOLISM
      Umemura Y, Al-Holou W, Marini B, Leung D, Kim M, Ferris S, Junck L, Sagher O, Heth J, Sun Y, Schipper M, Lyssiotis C, Lawrence T, Wahl D. Neuro-Oncology, 2022 Nov 14; 24 (Supplement_7): vii79 - vii79. DOI:10.1093/neuonc/noac209.300
    • Proceeding / Abstract / Poster
      NIMG-21. INTERIM ANALYSIS OF A PHASE II STUDY OF MULTIPARAMETRIC MR-GUIDED HIGH-DOSE RESPONSE-ADAPTIVE RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
      Kim M, Aryal M, Rosen B, Parmar H, You D, Junck L, Leung D, Umemura Y, Heth J, Al-Holou W, Hollon T, Wahl D, Lawrence T, Cao Y. Neuro-Oncology, 2022 Nov 14; 24 (Supplement_7): vii166 - vii166. DOI:10.1093/neuonc/noac209.639
    • Proceeding / Abstract / Poster
      NEIM-08 A PHASE II STUDY OF MULTIPARAMETRIC MR-GUIDED HIGH DOSE ADAPTIVE RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
      Kim M, Aryal M, Rosen B, Parmar H, You D, Junck L, Leung D, Umemura Y, Heth J, Al-Holou W, Hollon T, Wahl D, Lawrence T, Cao Y. Neuro-Oncology Advances, 2022 Aug 5; 4 (Suppl 1): i19 - i19. DOI:10.1093/noajnl/vdac078.075